1. Home
  2. PCLA vs GBIO Comparison

PCLA vs GBIO Comparison

Compare PCLA & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCLA
  • GBIO
  • Stock Information
  • Founded
  • PCLA 2008
  • GBIO 2016
  • Country
  • PCLA Japan
  • GBIO United States
  • Employees
  • PCLA N/A
  • GBIO N/A
  • Industry
  • PCLA Building Products
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PCLA Consumer Discretionary
  • GBIO Health Care
  • Exchange
  • PCLA Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • PCLA 71.3M
  • GBIO 29.2M
  • IPO Year
  • PCLA 2025
  • GBIO 2020
  • Fundamental
  • Price
  • PCLA $0.81
  • GBIO $0.43
  • Analyst Decision
  • PCLA
  • GBIO Strong Buy
  • Analyst Count
  • PCLA 0
  • GBIO 4
  • Target Price
  • PCLA N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • PCLA 3.2M
  • GBIO 1.2M
  • Earning Date
  • PCLA 01-01-0001
  • GBIO 08-06-2025
  • Dividend Yield
  • PCLA N/A
  • GBIO N/A
  • EPS Growth
  • PCLA N/A
  • GBIO N/A
  • EPS
  • PCLA N/A
  • GBIO N/A
  • Revenue
  • PCLA $5,475,228.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • PCLA N/A
  • GBIO N/A
  • Revenue Next Year
  • PCLA N/A
  • GBIO N/A
  • P/E Ratio
  • PCLA N/A
  • GBIO N/A
  • Revenue Growth
  • PCLA 40.19
  • GBIO 146.47
  • 52 Week Low
  • PCLA $0.37
  • GBIO $0.30
  • 52 Week High
  • PCLA $9.80
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • PCLA N/A
  • GBIO 60.24
  • Support Level
  • PCLA N/A
  • GBIO $0.32
  • Resistance Level
  • PCLA N/A
  • GBIO $0.36
  • Average True Range (ATR)
  • PCLA 0.00
  • GBIO 0.03
  • MACD
  • PCLA 0.00
  • GBIO 0.01
  • Stochastic Oscillator
  • PCLA 0.00
  • GBIO 78.75

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: